People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Imvax, Inc. | — | Biotechnology | Series D+ | $151.8M | $4.6B | 2020 |
John W Furey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John W Furey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Andrews | 1 | 3 |
| Arthur W. Howe | 1 | 2 |
| Wendy W. DiCicco | 1 | 2 |
| Steven W Altschuler | 1 | 1 |
| David W Bunning | 1 | 1 |
| Thomas W Pfisterer | 1 | 1 |
| Peter W Corr | 1 | 1 |
| Ted W Koutouzis | 1 | 1 |
| Ira W Brind | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.